Skip to content

Myriad Genetics MYGN Enterprise value

Enterprise value at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$28.24B+10.2%
Quest Diagnostics logo
Quest DiagnosticsDGX
$27.54B+9.5%
NeoGenomics logo
NeoGenomicsNEO
$883.35M-5.6%
Veracyte logo
VeracyteVCYT
$2.33B+7.4%
Guardant Health logo
Guardant HealthGH
$12.72B+121%
Natera, Inc. logo
Natera, Inc.NTRA
$27.5B+49.9%

Other financials

Income statement

See full
Revenue$200.4M+2.3%
Gross profit$137.6M+2.5%
Operating income-$30.7M-5.9%
Net income-$34.1M-34,000%
EPS (diluted)-$0.36

Balance sheet

See full
Cash & equivalents$126.0M+24.8%
Total debt$211.5M+34.2%
Total equity$337.4M-52.1%
Total assets$673.7M-33.0%

Cash flow

See full
Operating cash flow-$15.7M+3.7%
CapEx$18.8M+181%
Free cash flow-$19.7M+65.1%

Valuation

See full
Market cap$512.85M+13.1%
P/S0.6×+0.1×

Profitability

See full
Gross margin70%0.0pp
Operating margin-46.9%-88.3pp
Net margin-48.2%-72.9pp
FCF margin-17%

Returns & leverage

See full
Return on equity-76.7%-98.4pp
Debt / equity0.6×+0.4×
Current ratio2.4×+0.5×

Where this comes from

Calculated from Myriad Genetics’s reported figures.

The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Myriad Genetics's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Myriad Genetics's enterprise value?
Myriad Genetics (MYGN) reported enterprise value of $506.29M in Q1 2026.
How has Myriad Genetics's enterprise value changed year-over-year?
Myriad Genetics's enterprise value decreased by 41.6% year-over-year, from $866.51M to $506.29M.
What is the long-term trend for Myriad Genetics's enterprise value?
Over 5 years (2020 to 2025), Myriad Genetics's enterprise value has grown at a -18.4% compound annual growth rate (CAGR), from $1.75B to $631.76M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.